Eiko LifeSciences Limited (BOM:540204)

India · Delayed Price · Currency is INR

50.79

+2.00 (4.10%)

At close: Mar 25, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
Speciality Chemicals & Pharma Intermediates	279.29M	183.21M	260.54M	124.01M
Speciality Chemicals & Pharma Intermediates Growth	52.44%	-29.68%	110.11%	19.12%
Total	279.29M	183.21M	260.54M	124.01M
Total Growth	52.44%	-29.68%	110.11%	19.12%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019	Mar '18 Mar 31, 2018	Mar '17 Mar 31, 2017	Mar '16 Mar 31, 2016
India	357.36M	279.29M	179.76M	236.76M	75.55M
India Growth	27.95%	55.37%	-24.07%	213.37%	-27.43%
Export	2.96M	-	3.42M	17.36M	44.35M
Export Growth	-	-	-80.32%	-60.85%	-
Unallocated	16.32M	-	36.00K	205.00K	-
Unallocated Growth	-	-	-82.44%	-	-
Total	376.64M	279.29M	183.22M	254.33M	119.91M
Total Growth	34.85%	52.44%	-27.96%	112.11%	15.18%

Source: S&P Global Market Intelligence.